GlassScriptPhysician profile
Gareth T Miller
NPI 1831910751
$1,119.88
in general payments reported to CMS, 2019-2025
17 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $849 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $935.94 |
| Education | $183.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $315.37 | 2024 | Darzalex, Tecvayli, Talvey |
| Abbvie INC. | $165.69 | 2024 | |
| Emd Serono, INC. | $138.46 | 2024-2025 | |
| Incyte Corporation | $113.13 | 2024-2025 | Pemazyre, Monjuvi |
| Merck Sharp & Dohme LLC | $67.09 | 2024-2025 | Keytruda |
| Astrazeneca Pharmaceuticals LP | $55.82 | 2024 | Lynparza, Enhertu, Imfinzi |
| Regeneron Healthcare Solutions, INC. | $48.30 | 2024 | Libtayo |
| Urgo Medical North America, LLC | $27.95 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Pfizer INC. | $25.11 | 2024 | |
| Jazz Pharmaceuticals INC. | $24.25 | 2024 | |
| Aveo Pharmaceuticals, INC. | $22.65 | 2025 | |
| Lilly USA, LLC | $22.19 | 2024 | Retevmo, Jaypirca, Verzenio |
| Bayer Healthcare Pharmaceuticals INC. | $21.91 | 2025 | |
| Daiichi Sankyo INC. | $21.36 | 2025 | Injectafer |
| Stemline Therapeutics INC. | $20.31 | 2025 | Orserdu |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Taiho Oncology, INC. | $15.68 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $14.61 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gareth Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.